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OBJECTIVE—High molecular weight (HMW) adiponectin is
a predominant isoform of circulating adiponectin and has been
related to type 2 diabetes. Previous linkage studies suggest that
different genetic components might be involved in determining
HMW and total adiponectin levels.
RESEARCH DESIGN AND METHODS—We performed a
genome-wide association study (GWAS) of serum HMW adipo-
nectin levels in individuals of European ancestry drawn from the
Nurses’ Health Study (NHS) (N = 1,591). The single nucleotide
polymorphisms (SNPs) identiﬁed in the GWAS analysis were rep-
licated in an independent cohort of Europeans (N = 626). We
examined the associations of the identiﬁed variations with di-
abetes risk and metabolic syndrome.
RESULTS—We identiﬁed a novel locus near the FER gene
(5q21) at a genome-wide signiﬁcance level, best represented by
SNP rs10447248 (P = 4.69 3 10
28). We also conﬁrmed that vari-
ations near the adiponectin-encoding ADIPOQ locus (3q27) were
related to serum HMW adiponectin levels. In addition, we found
that FER SNP rs10447248 was related to HDL cholesterol levels
(P = 0.009); ADIPOQ variation was associated with fasting glu-
cose (P = 0.04), HDL cholesterol (P = 0.04), and a metabolic
syndrome score (P = 0.002).
CONCLUSIONS—Our results suggest that different loci may be
involved in regulation of circulating HMW adiponectin levels and
provide novel insight into the mechanisms that affect HMW
adiponectin homeostasis. Diabetes 60:2197–2201, 2011
A
diponectin is the most abundant adipocyte-
secreted hormone in blood (1), which regulates
the inﬂammatory response, enhances insulin
action, and affects metabolism of glucose and
lipids (2,3). In the circulation, adiponectin is present in
multimers of various molecular weights including high
(HMW), medium (MMW), and low (LMW) molecular weight,
with the predominant form being HMW adiponectin (4),
which is thought to represent the biological active form that
is better correlated with insulin sensitivity and risk of obe-
sity and diabetes than total adiponectin (5,6).
Family and twin studies indicate that 30–88% variance
in adiponectin concentration is potentially accounted for
by genetic inﬂuence (4,7,8). Candidate gene studies and
genome-wide association studies (GWAS) of total adipo-
nectin levels have identiﬁed loci near genes ADIPOQ,
ARL15, and CDH13 (8–14). Previous linkage studies in-
dicate that different loci might be involved in determining
HMW adiponectin (15). We therefore undertook a genome-
wide analysis on the serum levels of HMW adiponectin. We
describe the identiﬁcation of a novel locus at genome-wide
signiﬁcance level.
RESEARCH DESIGN AND METHODS
The Nurses’ Health Study (NHS) was established in 1976 when 121,700 female
registered nurses aged 30–55 years and residing in 11 large U.S. states com-
pleted a mailed questionnaire on their medical history and lifestyle (16). The
lifestyle factors have been updated by validated questionnaires every 2 years.
The current study was approved by the institutional review board at Brigham
and Women’s Hospital. Participants for the current study were a subset of
women (N = 1,591) included in a nested case-control study of type 2 diabetes
(17,18). To test the association with diabetes risk, we also included a nested
case-control study in the Health Professional Follow-up Study (HPFS) (17)
(Supplementary Materials).
Replication study. A total of 626 nondiabetic individuals (240 men and 386
women) from 235 families were recruited in the Gargano area in center-east
Italy and examined as previously described. The study and the informed
consent procedures were approved by the local research committee. A met-
abolic syndrome score was calculated according to Adult Treatment Panel III
criteria.
Assessment of serum adiponectin. In NHS, study samples were analyzed in
randomly ordered case-control pairs to further reduce systematic bias and
interassay variation. Serum HMW adiponectin concentrations were determined
by ELISA (Millipore, St. Charles, MO) with a sensitivity of 0.5 mg/mL.
In the Italian sample, serum total adiponectin HMW and MMW plus HMW
adiponectin concentrations were measured by ELISA (ALPCO) as previously
described (4). MMW values were obtained by subtracting the concentrations
of HMW from the combined concentrations of MMW plus HMW. LMW adi-
ponectin fractions were obtained by subtracting the combined concentrations
of MMW plus HMW from the total adiponectin concentrations. The intra-assay
coefﬁcients of variation were 5.4 and 5.0, 5.2 and 4.9, and 5.0 and 4.8% for
total adiponectin, MMW plus HMW adiponectin, and HMW adiponectin,
respectively.
Genotyping and quality control. For the GWAS samples, genotyping was
doneusingtheAffymetrix Genome-WideHuman6.0array.Genotypic datawere
checked for quality as described elsewhere (17,18). We used MACH (http://
www.sph.umich.edu/csg/abecasis/MACH) to impute 2,543,887 single nucleo-
tide polymorphisms (SNPs) on chromosomes 1–22 with NCBI build 36 of
Phase II HapMap CEU data (release 22) as the reference panel. Imputed SNPs
with minor allele frequency ,0.02 and/or with poor imputation quality scores
(MACH r
2 #0.30) were ﬁltered from analysis. Population structure was in-
vestigated by principal component analysis. Adjustment for the top four
principal components did not appreciably change the association results.
Replication SNPs were genotyped by Taqman SNP allelic discrimination
technique by means of an ABI 7000 (Applied Biosystems, Foster City, CA). Call
rate and concordance rate were $96 and .99%, respectively. All the SNPs
were in Hardy-Weinberg equilibrium (P . 0.05).
Statistical analyses. GWAS analysis on HMW adiponectin levels in NHS was
performed with the linear regression analysis using PLINK software. HMW
adiponectin was normally distributed and analyzed without transformation.
Associations between adiponectin isoforms and each SNP in the replication
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BRIEF REPORTsample weretestedbyalinearmixed-effectsmodel implemented inSOLARthat
accounts for within-family correlations. Each SNP was included in a model as
a ﬁxed effect with additive coding. We combined study-speciﬁc b-estimates
from discovery and replication analyses using the inverse of the variance of
the study-speciﬁc b-estimates to weight the contribution of each study with
the ﬁxed-effect model. The associations between SNPs and the risk of type 2
diabetes in NHS and HPFS were analyzed using a logistic regression model. To
assess phenotypic correlations between HMW adiponectin and metabolic
traits in the Italian samples, we used a mixed-effects model by SOLAR that
includes ﬁxed covariate effects. This method could account for the de-
pendence of the family data and provide a more stringent P value. All analyses
were adjusted for sex, age, and BMI.
RESULTS
We performed GWAS analyses with serum HMW adipo-
nectin levels in 1,591 women (698 diabetic patients) from
the NHS. The characteristics of the participants are pre-
sented in Supplementary Table 1. We ﬁt a linear regression
model for genotype trend effects (1 df), adjusting for age,
BMI, and diabetes status. Quantile-quantile plots (Supple-
mentary Fig. 1) suggest that there was no systemic bias for
analyses (genomic inﬂation factor, l= 0.998). Further ad-
justment for fasting status, smoking, alcohol consumption,
and physical activity did not change the results.
Supplementary Fig. 2 shows the plots of the –log10
P values for the trend test for serum HMW adiponectin.
No associations with HMW adiponectin levels reached
genome-wide signiﬁcance level (P =53 10
28). We took
SNPs representing independent loci with P , 5 3 10
26
for further replication (Table 2). In addition, we chose the
two best associated but not correlated (r
2 =0.05) SNPs
at the ADIPOQ (3q27) loci, rs3774261 and rs822354, for
replication.
The replication samples include 626 white Italian sub-
jects (240 men and 386 women). Two ADIPOQ SNPs,
rs822354 and rs3774261, showed directionally consistent
and nominally signiﬁcant associations with serum HMW
adiponectin in the replication sample (Table 1), and the
association of rs822354 reached genome-wide signiﬁcance
in meta-analysis of the two studies (P = 3.67 3 10
28). SNP
rs822354 accounted for 1.1 and 2.5% of the variance in
HMW adiponectin levels in the NHS and Italian samples,
respectively. Another SNP, rs10447248 (5q21), also showed
directionally consistent associations with HMW adiponectin
levels (P =4 . 2 7 3 10
23) in the replication samples. In the
meta-analysis, the association of rs10447248 reached
genome-wide signiﬁcance level (4.69 3 10
28)( T a b l e1 ;
Fig. 1). Each A allele of SNP rs10447248 was related to
0.76 and 0.39 mg/mL lower HMW adiponectin and ac-
counted for 1.3 and 2% of the variance in the NHS and
Italian samples, respectively.
SNP rs2468677 (8q24) also showed directionally con-
sistent and marginal association with HMW adiponectin
levels in the replication set (P = 0.0607). In the meta-
analysis, the association between rs2468677 and HMW
adiponectin levels was near genome-wide signiﬁcance (P =
7.95 3 10
27).
We further examined the impact of the newly identiﬁed
SNP rs10447248 in the FER locus on the serum levels of
other isoforms, MMW and LMW adiponectin, that were
measured in the Italian samples. The A allele of SNP
rs10447248 was nominally associated with lower MMW
(P = 0.016) but was not associated with LMW (P . 0.05)
(Fig. 2) adiponectin levels.
To get deeper insights about the associations between
the newly identify FER locus and HMW adiponectin levels,
we performed genotyping imputation in the NHS samples
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near FER showed stronger association with serum HMW
adiponectin (P =1 . 0 73 10
27) than SNP rs10447248 (Fig. 1).
The two SNPs are in moderate linkage disequilibrium
(r
2 = 0.5). When included in the same regression model,
both SNPs rs10447248 and rs11749751 showed independently
and nominally signiﬁcant associations with HMW levels
(P = 0.0018 and 0.0044, respectively).
We further examined the associations between the
HMW adiponectin–associated SNPs with the risk of type 2
diabetes in NHS and HPFS and with the metabolic traits in
the Italian samples. After adjustment for age, BMI, and
fasting status, the allele A of ADIPOQ SNP rs822354 was
related to a decreased risk of diabetes in the HPFS (odds
ratio [OR] 0.87 [95% CI 0.78–0.98]) but not in the NHS (1.00
[0.98–1.03]). FER SNPs were not associated with diabetes
risk. In Italian samples, allele A of ADIPOQ SNP rs822354
was associated with a lower metabolic syndrome score
(P = 0.002) (Table 2), lower fasting glucose (P = 0.04), and
higher HDL cholesterol levels (P = 0.04). In our sample,
HMW adiponectin and metabolic syndrome score share
a common genetic background as indicated by a signiﬁ-
cant genetic correlation. Of note, ADIPOQ SNP rs822354
could explain 3% of the genetic correlations between the
two variables (rg=20.32 6 0.14) (P = 0.04). FER SNP
rs10447248 was not signiﬁcantly related to metabolic
syndrome score but was associated with lower levels of
HDL cholesterol (P = 0.009).
DISCUSSION
In this study, we found novel genome-wide signiﬁcant
associations of SNPs on chromosome 5q21 with serum
HMW adiponectin levels in Caucasians with European
ancestry. SNP rs10447248 is ;170 kb upstream the FER
gene (Fig. 1). Fer protein is a member of the FPS/FES
family of nontransmembrane receptor tyrosine kinases.
Animal studies suggest that FER has a role in regulating
inﬂammation and innate immunity (20,21). However, there
are no available data for the roles of this gene product in
regulating adiponectin production.
We conﬁrmed that common SNPs near/in ADIPOQ locus
were associated with serum HMW adiponectin levels. The
results are consistent with the previous studies (4,11,14).
Interestingly, we found that multiple genetic variations in
low linkage disequilibrium were related with HMW adipo-
nectin levels, suggesting that allelic heterogeneity may
exist at this locus in affecting the homeostasis of the
marker. Another locus near the KCNK9 gene on chromo-
some 8q24 also showed suggestive association with HMW
adiponectin levels. Of note, in a previous genome-wide
scan this locus was related to the levels of triglycerides (22).
SNPs in genes ARL15 (rs4311394) and CDH13 (rs3865188
and rs7195409) were recently associated with total or HMW
adiponectin levels (11,12,14). However, neither locus was
FIG. 1. Region plot of FER locus. Association signals at chromosome 5q21, across a region centering on SNP rs10447248, with HMW adiponectin
levels in NHS. The vertical axis represents the –log10 P values from the linear regression analysis for the genotyped and imputated SNPs.
FIG. 2. Associations of SNP rs10447248 with adiponectin isoforms.
Levels of circulating HMW, MMW, and LMW adiponectin by the geno-
types of SNP rs10447248 in Italian samples. The P values are from the
trend test in linear regression model. The analyses were adjusted for
age, sex, and BMI.
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or another GWAS in Europeans (13). It appears that the
genetic effects of the CDH13 locus were more signiﬁcant
in Asian populations (11,12).
Previous linkage analyses suggest that different loci may
be involved in regulating total and HMW adiponectin levels
(15,23). It is noteworthy that circulating adiponectin levels
may be regulated at different levels including transcrip-
tion, translation, and posttranslational levels such as pro-
tein modiﬁcation, secretion, oligomerization, degradation,
and excretion, as well as clearance (24). It is likely that the
genetic variants affecting these various steps may modu-
late HMW adiponectin levels and that ADIPOQ locus may
affect transcription of the gene. The mechanisms un-
derlying the associations for FER locus remain to be
clariﬁed in future function studies.
HMW adiponectin levels have been previously related to
metabolic traits such as plasma insulin, insulin resistance,
and risk of type 2 diabetes (5,6,25). SNP rs822354 was
related to a reduced risk of diabetes in HPFS and lower
metabolic syndrome score in Italian samples; however, the
SNP was not signiﬁcantly associated with diabetes risk in
NHS. No SNP by sex interaction in modulating metabolic
syndrome score was observed in the Italian sample (P =
0.48). SNPs at the FER locus were not related to diabetes
risk or metabolic syndrome score. Of note, these SNPs
only account for a small proportion of the variance in
HMW adiponectin levels. This may partly explain the weak
relation between the genetic variations and disease risk.
The major strengths of our study included a well-deﬁned
cohort, high-quality genotype data, and minimal population
stratiﬁcation (17). We acknowledge several study limi-
tations, including potential errors in biomarker measure-
ments. Nevertheless, these errors more likely bias the
association toward null because the measurement errors
are uncorrelated with genotyping. The discovery samples
include only women while the replication samples include
both sexes. However, the previous GWAS did not report
sex-speciﬁc genetic effects on adiponectin. In addition, the
Italian cohort consists only of nondiabetic subjects and
may not represent the general population, and all study
populations exclusively consist of Caucasians with Euro-
pean ancestry. Therefore, the ﬁndings may not be gener-
alizable to other ethnicities.
In conclusion, we found a novel locus at the FER gene
(5q21) associated with serum HMW adiponectin levels and
provided conﬁrmatory evidence for the ADIPOQ locus
with HMW adiponectin levels. Future studies may in-
vestigate the potentially additive nature of multiple path-
ways in regulation of HMW adiponectin concentrations
and whether these genetic variants may affect disease risk
associated with adiponectin deﬁciency.
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